See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367644_2025_Emergent_Biosolutions_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 1043600000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.313475997686524, 'aggregate_val': 1200000000, 'exp_sum': 518700000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 308000000, 'ResearchAndDevelopmentExpense': 70700000, 'remainder_Expenses': 140000000}} |
Graph
Absolute values for 0001367644, Emergent Biosolutions Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 598,700,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 501,500,000 |
| 2 | PropertyPlantAndEquipmentNet | 270,600,000 |
| 3 | remainder_Assets | 18,900,000 |
| 4 | LiabilitiesCurrent | 162,400,000 |
| 5 | LiabilitiesNoncurrent | 702,800,000 |
| 6 | remainder_Liabilities | 41,700,000 |
| 7 | CostOfGoodsAndServicesSold | 199,920,803 |
| 8 | SellingGeneralAndAdministrativeExpense | 297,251,724 |
| 9 | ResearchAndDevelopmentExpense | 62,122,623 |
| 10 | remainder_Expenses | 743,687,736 |
| 11 | remainder_Revenues | 1,041,937,456 |
| 12 | remainder_NetIncome | -24,218,072 |
| 13 | remainder_ComprehensiveNetIncome | -1,534,447 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,389,700,000 |
| 1 | Liabilities | 906,900,000 |
| 2 | Expenses | 1,302,982,886 |
| 3 | Revenues | 1,041,937,456 |
| 4 | StockholdersEquity | 482,800,000 |
| 5 | NetIncome | -285,263,502 |
| 6 | ComprehensiveNetIncome | -286,030,726 |
| 7 | BaseVar | 2,333,636,430 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.667 |
| 9 | EconomicCapitalRatio | 2.03 |
Edgar->Model Mapping
Feature Distribution
Change over Time
